At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 13 enrolled
Drug / intervention
Milnacipran +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Ten-Week, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study of Milnacipran for Radicular Pain Associated With Lumbosacral Disk Disease
In Brief
A Phase 4 clinical trial evaluating Milnacipran and Placebo for Radicular Pain Related to Lumbosacral Disc Disease. Completed, enrolled 13 participants.
Detailed Summary
This study investigates whether milnacipran reduces radicular pain ("sciatica") in patients with lumbosacral disc disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
CollaboratorsForest Laboratories
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2010
Primary CompletionOct 2011
First PostedJan 2013
TodayJul 2026
First PostedJan 29, 2013
Enrollment StartMar 1, 2010
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 13.4 years ago
Interventions
Milnaciprandrug
Placebodrug